Today's Daily Dose brings you news about promising trial results of Acceleron Pharma's investigational drug Luspatercept in beta-thalassemia; FDA granting Orphan Drug Designation to Cellectar Biosciences' phase I drug candidate; FDA clearance of GammaTile Therapy and its effect on IsoRay and KemPharm's encouraging results from its pivotal efficacy and safety clinical trial of KP415 in ADHD.
from RTT - Biotech https://ift.tt/2ugCowg
via IFTTT
No comments:
Post a Comment